Product Name:

NebuPeptide™ Insulin Aspart (Peptide Reference)

Catalog Number:

NBS-233759

Description:

NebuPeptide™ Insulin Aspart (Peptide Reference)(CAT#NBS-233759) is synthesized in accordance with the Insulin Aspart sequence and can be utilized for a variety of in vivo and in vitro studies, including quality control, bioactivity verification, immunization, drug development, structural analysis, etc. Nebula Biotechnology Co., Ltd. is capable of providing Insulin Glargine reference peptide ranging from milligrams to kilograms.

Peptide Name:

Insulin Aspart (门冬胰岛素)

Background:

Insulin aspart (B28Asp) is a rapidly acting human insulin analogue. After subcutaneous injection, Insulin aspart absorbs insulin faster than ordinary people. Insulin aspart can be used in the study of diabetes.

Alias:

B28Asp; B28-Asp-insulin; INA-X 14; Insulin X 14

CAS Number:

116094-23-6

Formula:

C256H381N65O79S6

Molecular Weight:

5831.59

Purity:

see COA

Solubility:

see COA

Storage & Shipment:

Store at -20℃; ship with blue ice.

For R&D use only!

To get more information, please contact us freely.